Bradford Perez, MD
Radiation Oncology · Trinity, FLNPI 1578887725
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,909 of the $30,363 with a category attached, or 65.6%. 34 manufacturers reported payments, led by AstraZeneca at 40.1% of the total. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $178.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$12K
- Daiichi Sankyo Inc.$7K
- Novocure Inc.$5K
- E.r. Squibb & Sons, L.L.C.$2K
- G1 Therapeutics, Inc.$2K
- Novartis$444
- plus $2K from 28 others
Across 4 payments — averaging $20,191 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$80K
- E.r. Squibb & Sons, L.L.C.$800
What the payments were for
- Consulting fees$19,90966%
- Speaking & faculty fees$5,67519%
- Travel & lodging$7132%
- Food & beverage$4,06613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 23 | $12,190 |
| Daiichi Sankyo Inc. | 9 | $6,930 |
| Novocure Inc. | 9 | $4,818 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,094 |
| G1 Therapeutics, Inc. | 1 | $1,500 |
| Novartis | 29 | $444 |
| Merck | 15 | $347 |
| Johnson & Johnson | 18 | $320 |
| Bayer | 6 | $217 |
| Incyte Corporation | 8 | $174 |
| Genentech, Inc. | 1 | $150 |
| Medtronic | 1 | $145 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Sobi, Inc | 5 | $91 |
| Pfizer | 5 | $88 |
| Sanofi | 4 | $83 |
| AbbVie | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Array Biopharma Inc | 2 | $52 |
| Pharmacosmos Therapeutics Inc. | 3 | $47 |
| Taiho Oncology, Inc. | 3 | $46 |
| Reflexion Medical, Inc. | 1 | $46 |
| Eisai Inc. | 2 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| GSK | 2 | $37 |
| Tersera Therapeutics LLC | 1 | $35 |
| AVEO Pharmaceuticals, Inc. | 2 | $32 |
| Immunogen, Inc. | 1 | $28 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTUNE LUA (NOVOTTF-200T)$4,175
- IMFINZI$3,690
- OPDIVO$2,094
- COSELA$1,500
- TAGRISSO$410
- TECENTRIQ$150
- OSTEOCOOL RF ABLATION SYSTEM$145
- Xofigo$117
How this compares
$30,363 in reported general payments places this provider in the 90th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 35 | $963 |
| Ondansetron OdtOndansetron | 14 | $497 |
| Tamsulosin Hcl | 38 | $322 |
| Dexamethasone | 21 | $248 |
| Lidocaine Hcl ViscousLidocaine Hcl | 17 | $238 |
| Methylprednisolone | 18 | $151 |
| Nystatin | 12 | $138 |
| Lorazepam | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Trinity
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
- Alan BrownFort Myers$165K
- Akash NandaOrlando$165K
- Michael ChuongMiami$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.